Hand Rejuvenation With Dermal Fillers: Options for a Naturally Refreshed Look

Hand fillers can add volume to the backs of the hands when a clinician identifies a volume deficit. That is a different question from treating brown spots or a dry, rough surface. The useful starting point is the change you notice, followed by an assessment of whether any procedure is appropriate. FDA filler guidance.

A naturally refreshed appearance is a goal to discuss, not a promised result. Here is what the hand-specific evidence supports and what to ask before making a decision.

Start with the hand concern

Describe the concern in your own words: hollowness on the backs of the hands, more visible tendons, brown spots, dryness or changes in the skin’s surface. These observations can lead to different discussions.

The hand indications discussed below concern volume loss. They do not establish that filler removes pigmentation, treats a new skin lesion or corrects every form of crepey skin. Ask the clinician to distinguish the volume question from surface or medical skin concerns before proposing treatment. Restylane Lyft hand labeling, Radiesse hand labeling.

Our broader fillers and skincare comparison introduces the distinction between structural and surface goals. A hand assessment still needs its own product-specific discussion.

Which fillers have hand-volume indications?

Restylane Lyft with Lidocaine is a hyaluronic acid filler with a US FDA indication for correcting volume deficit in the backs of the hands in patients over 21. Radiesse injectable implant, a calcium hydroxylapatite product, has an FDA indication for correcting volume loss in the backs of the hands. These are specific product indications; they do not apply to every filler in either material family. FDA Restylane Lyft IFU, FDA Radiesse IFU.

Ask for the exact product name, its patient information and whether the proposed use matches that product’s labeling. Approval for a facial area does not automatically establish approval for the hands. Our Sculptra and Radiesse comparison explains why material and approved use deserve separate attention.

What the hand studies can tell you

A randomized, evaluator-blinded study compared Restylane Lyft treatment in one hand with the person’s untreated other hand. In its 85-person efficacy population, 85.9% of treated hands versus 21.2% of untreated hands improved by at least one grade on a hand-volume scale at week 12. Improvement was assessed through 24 weeks. The participants were 37–77 and mostly white women; the study was manufacturer funded. These findings support a possible volume benefit, with limits on how broadly the result can be generalized. Original 2019 study.

FDA’s original Radiesse trial record describes 114 evaluable adults, assigned to immediate treatment or a delayed-treatment control. At three months, 75.3% of treated participants versus 3.4% of controls met its hand-scale improvement endpoint. Participants were 26–79 and mostly women. The FDA also examined variation between study sites. FDA trial summary.

These were separate studies, not a direct contest between the products. Their percentages cannot establish which is better for you. Neither endpoint means that brown spots disappeared or that every participant achieved the same appearance.

Timing also needs context. The FDA Restylane patient brochure describes hand benefits usually lasting about six months. That is a general study-based description, not a personal maintenance schedule. Ask when your response would be reviewed, whether the evidence included touch-ups and what would justify another treatment. FDA patient brochure.

Recovery should include hand function

Discuss the tasks you need your hands for, including work, exercise and caring for others. Swelling, bruising, pain and tenderness can affect recovery; a short appointment does not establish an immediate return to every activity. The Radiesse hand instructions specifically warn about temporary difficulty performing activities and about nodules or lumps that can persist. The Restylane Lyft hand label also warns that some reactions can last for months and reports reduced thumb movement in its clinical study. FDA Restylane Lyft hand instructions. Ask for written, product-specific aftercare and an assessment plan for persistent or worsening symptoms. Radiesse hand instructions.

Filler injection is a medical procedure. Infection and delayed reactions can occur. Unintended injection into a blood vessel can interrupt the blood supply and cause serious tissue injury. Unusual pain or white, gray or blue skin around an injection needs immediate medical attention. Seek emergency care for vision changes or stroke symptoms; these are serious filler warnings, with such complications reported after facial injections. FDA safety information.

Bring your medication and supplement list, allergy history and previous treatment records. Mention hand surgery or injury, circulation problems including Raynaud’s, and any joint or tendon disease. Ask how pregnancy or breastfeeding, active skin problems and your health history affect suitability. Do not stop prescribed medicines on your own. Radiesse hand instructions, FDA filler guidance.

Questions to bring to a consultation

1. Is my concern mainly volume loss, a surface change or something that needs medical skin assessment?
2. Which exact product would you consider, and what does its hand-specific labeling cover?
3. What experience do you have assessing and treating hands, and how would you evaluate my hand function?
4. What change is realistic for me, and what would treatment leave unchanged?
5. How could recovery affect my daily tasks, and whom do I contact urgently if something seems wrong?
6. When would you reassess the result, and what are the alternatives, including choosing no procedure?
7. What is the complete proposed cost, including follow-up, and what could change that estimate?

Confirm the clinic treats hands and which product it uses before arranging a visit. Our filler consultation guide can help organize the wider conversation. Leave with a clear explanation of the proposed benefit, the limits and the follow-up plan before deciding.